The quarter beat its own growth story but missed the published EPS bar. Amrize delivered strong volume-led revenue growth, but adjusted diluted EPS of $0.88 came in below the published consensus estimate of roughly $0.95, making the headline earnings result a miss despite year-over-year gains.
| Metric | Q2 2026 | Q2 2025 / expectation | Read |
|---|---|---|---|
| Revenue | $3,494M (Consolidated Results) | $3,218M (Consolidated Results) | +8.6% |
| Organic growth | 6.7% (Financial Highlights) | — | Strong demand |
| Adjusted EBITDA | $986M (Consolidated Results) | $932M (Consolidated Results) | +5.8% |
| Adjusted EBITDA margin | 28.2% (Consolidated Results) | 29.0% (Consolidated Results) | Down 80 bps |
| Adjusted diluted EPS | $0.88 (Consolidated Results) | $0.81 (Consolidated Results) | Below published consensus of ~ $0.95 |
| FY 2026 revenue guidance | $12.5B–$12.7B (Full Year Financial Guidance) | $12.29B–$12.52B prior range | Raised |
| FY 2026 adjusted EBITDA guidance | $3.1B–$3.2B (Full Year Financial Guidance) | $3.25B–$3.34B prior range | Cut materially |
Revenue quality was genuinely strong, especially in Building Materials. Volumes rose 5.0% in cement and 6.5% in aggregates, while freight-adjusted aggregates pricing increased 4.0%; Building Materials EBITDA grew 5.2% to $793 million despite a 100-basis-point margin decline (Building Materials Results). That supports the demand and pricing thesis rather than growth being driven mainly by acquisitions.
The key problem is that cost inflation is arriving faster than pricing. The EBITDA bridge shows $89 million of volume benefit, $16 million from pricing and $29 million of ASPIRE savings, but $75 million of higher costs, primarily freight, diesel and raw materials, plus a $17 million insurance comparison headwind (Q2 2026 EBITDA Bridge). Building Envelope is the clearest weak spot: revenue rose 9.4%, but EBITDA fell 5.2% to $237 million and margin contracted 350 basis points to 22.6% (Building Envelope Results).
The guidance change is the most important market signal. Management raised the revenue range as demand improved, but cut the adjusted EBITDA midpoint from about $3.295 billion to $3.15 billion—roughly $145 million, or 4.4%, lower. The filing attributes the reset to oil-price-driven input inflation and the timing gap between cost increases and price realization (Full Year Financial Guidance). In other words, demand is outperforming, but near-term earnings power is underperforming the prior plan.
The filing also introduces a credibility and controls overhang. Amrize disclosed a $78 million extended-warranty deferred-revenue understatement at December 31, 2025, along with other misstatements requiring revisions to prior-period financial statements; the company says they were not material to previously issued statements but would have been material to current-period and forecasted results if corrected immediately (Revision of Prior Period Financial Statements). That does not overturn the quarter, but it adds noise around reporting quality—particularly because the issue sits in the already pressured Building Envelope segment.
Net read: operationally strong demand, financially a negative reset versus expectations. The revenue raise, buyback launch and $502 million returned to shareholders are supportive, but they do not offset the EPS miss, margin compression, Building Envelope weakness and sizeable EBITDA-guidance cut. The filing shifts the story from growth acceleration to a test of whether pricing and ASPIRE savings can catch up with inflation in the second half.
Read the original 8-K on SEC EDGAR ↗